论文信息 - A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies - 字舞流文

A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies

I. Flinn | B. Keyt | P. Armand | W. Kim | M. Leabman | G. Gregory | M. Matasar | L. Nastoupil | C. Diefenbach | A. Gopal | G. Hernandez | Daniel S Chen | E. Budde | C. Cheah | I. Qazi | Ching-Fai Pang | I. Sison